MARVELD1 anticorps (N-Term)

N° du produit ABIN1887968

Détail du produit anti-MARVELD1 anticorps

Antigène: MARVELD1 (MARVEL Domain Containing 1 (MARVELD1))

Épitope: N-Term

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MARVELD1 est non-conjugé

Application: Western Blotting (WB), ELISA

Purification: Affinity chromatography purified via peptide column

Immunogène: 16 amino acid peptide from near the amino terminus of human MARVELD1.

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

Conseil sur la manipulation: Avoid freezing and thawing repeatly.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term use.Store at -20 °C for long term preservation.

Détails sur MARVELD1

Antigène: MARVELD1 (MARVEL Domain Containing 1 (MARVELD1))

Autre désignation: MARVELD1 (MARVELD1 Produits)

Synonymes: anticorps Mrvldc1, anticorps AI504298, anticorps GB14, anticorps MARVD1, anticorps MRVLDC1, anticorps RP11-548K23.8, anticorps bA548K23.8, anticorps MARVEL domain containing 1, anticorps MARVEL (membrane-associating) domain containing 1, anticorps Marveld1, anticorps MARVELD1

Sujet: MARVELD1, (MARVEL domain-containing 1), is one of the MARVEL (MAL and related proteins for vesicle trafficking and membrane link) domain-containing proteins.It is a nuclear-localized protein that is widely expressed in normal human tissues.While it has been reported to be overexpressed in colon cancer, MARVELD1 protein levels are generally lower in several primary tumors including ovary, breast, kidney, bladder and liver.This lower level of MARVELD1 expression in tumors is thought to be due to a higher methylation status of the MARVELD1 promoter as treatment of MDA-MB-361 with 5-aza-2'-deoxycytidine restores MARVELD1 expression, suggesting that loss of MARVELD1 expression may contribute to tumorgenicity.
Synonyms: MARVEL domain-containing 1, MARVD1, MRVLDC1, GB14